Similar Search Results

A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness

Refoios Camejo, Rodrigo; McGrath, Clare; Herings, Ron - In: Health Policy 100 (2011) 1, pp. 18-24

Limited healthcare budgets result in payers adopting policies at national, regional or local level to achieve allocative efficiency in drug spending. Some of these aim at creating a link between pharmaceutical prices and the value they provide by setting a cost effectiveness (CE) threshold as...

Persistent link: https://www.econbiz.de/10008871752

Productivity losses without absence: measurement validation and empirical evidence

Brouwer, W. B. F.; Koopmanschap, M. A.; Rutten, F. F. H. - In: Health Policy 48 (1999) 1, pp. 13-27

Persistent link: https://www.econbiz.de/10005516121

Productivity costs before and after absence from work: as important as common?

Brouwer, W. B. F.; van Exel, N. J. A.; Koopmanschap, M. A. - In: Health Policy 61 (2002) 2, pp. 173-187

Persistent link: https://www.econbiz.de/10005516245

Indirect costs of disease; an international comparison

van Roijen, Leona; Koopmanschap, Marc A.; Rutten, Frans … - In: Health Policy 33 (1995) 1, pp. 15-29

Persistent link: https://www.econbiz.de/10005508896

Market strategies for publicly financed health care systems

Rutten, Frans F. H. - In: Health Policy 7 (1987) 2, pp. 135-148

Persistent link: https://www.econbiz.de/10005509019

Health care financing in the Netherlands: recent changes and future options

Rutten, Frans F. H.; Freens, ReneJ. M. - In: Health Policy 6 (1986) 4, pp. 313-320

Persistent link: https://www.econbiz.de/10005516391

Analysis of costs and cost-effectiveness in multinational trials

Koopmanschap, Marc A.; Touw, Karien C. R.; Rutten, … - In: Health Policy 58 (2001) 2, pp. 175-186

Persistent link: https://www.econbiz.de/10005520399

The role of economic evaluation in the pricing and reimbursement of medicines

Drummond, Michael; Jonsson, Bengt; Rutten, Frans - In: Health Policy 40 (1997) 3, pp. 199-215

Persistent link: https://www.econbiz.de/10005520151

Economic evaluation and health care decision-making

Rutten, Frans - In: Health Policy 36 (1996) 3, pp. 215-229

Persistent link: https://www.econbiz.de/10005520561

Assessment of biotechnology drugs: what are the issues?

van Rijkom, Jeannette; Leufkens, Hubert; Crommelin, Daan; … - In: Health Policy 47 (1999) 3, pp. 255-274

Persistent link: https://www.econbiz.de/10005520570